Spain court hears case against German maker of Thalidomide (Update)

October 14, 2013

A Madrid court on Monday heard Spain's first lawsuit against German firm Grunenthal, the manufacturer of the morning sickness drug thalidomide which caused birth defects in thousands of babies.

The lawsuit was filed by Avite, an association representing Spaniards born with severe defects after their mothers took the drug during their pregnancies.

The group is seeking compensation of 204 million euros ($276 million) from the company for its roughly 180 members.

Dozens of Spaniards born with defects caused by the drug, many in wheelchairs or on crutches, arrived at the court for the one-day trial carrying a sign reading simply "Justice".

The group said on its website that it hoped the "historic lawsuit (would) appease the suffering of Spanish victims, which began in their mothers' wombs and continues today, with the amputation of their arms and legs".

Thalidomide was originally marketed as a sedative, but from the late 1950s was prescribed to women around the world to combat morning sickness.

Many of the children of the mothers who took the drug were born with abnormally short limbs and in some cases without any arms, legs or hips. In late 1961 the drug was withdrawn from the British and German markets.

But it continued to be sold in other countries including Spain, Canada and Japan for several more months.

The drug is estimated to have caused deformities in 10,000-20,000 babies in some 40 countries.

Avite estimates that up to 3,000 babies may have been born with deformities in Spain because of the drug.

"If the verdict agrees with our complaint, the German firm Grunenthal will officially be considered for the first time in history as being responsible for what has happened," the association said on its website.

Grunenthal has refused to accept liability but last year it issued its first ever apology for the scandal, saying it was "very sorry" for its silence towards victims of the drug.

The company's lawyers rejected the compensation demand, arguing that the case had exceeded the statute of limitations.

"The events took place over 50 years ago, which leads us to believe that the legitimacy of any legal procedure could be seriously compromised given the time that has elapsed," the company said in a statement.

The company also said Spanish victims could seek aid through two German foundations and potentially "receive the same economic benefits" as German victims.

A ruling in the case is expected in three weeks.

Explore further: Victims: Thalidomide sold in Spain post-withdrawal

Related Stories

Victims: Thalidomide sold in Spain post-withdrawal

May 8, 2013
(AP)—Spanish victims of thalidomide on Wednesday published documents they claim prove a German drug company kept distributing the notorious drug in Spain six months after it was taken off the market in other countries.

Australian wins millions in Thalidomide lawsuit

July 18, 2012
(AP) — An Australian woman born without arms and legs after her pregnant mother took the anti-morning sickness drug Thalidomide has reached a multimillion dollar settlement with the medicine's British distributor, her ...

Thalidomide maker 'ignored birth defects for years'

July 27, 2012
The German makers of thalidomide were warned of birth defects years before it was withdrawn and Australian distributors used pregnant women as the world's first test subjects, court papers alleged Friday.

Australian woman wins thalidomide hearing: court

December 19, 2011
A woman born without arms or legs on Monday won the right to have the class action she is leading against the firms behind thalidomide, a sedative blamed for birth defects, proceed in Australia.

German drug firm makes 1st apology for thalidomide (Update)

August 31, 2012
(AP)—The German manufacturer of a notorious drug that caused thousands of babies to be born with shortened arms and legs, or no limbs at all, issued its first ever apology Friday—50 years after pulling the drug off the ...

Recommended for you

In most surgery patients, length of opioid prescription, number of refills spell highest risk for misuse

January 17, 2018
The possible link between physicians' opioid prescription patterns and subsequent abuse has occupied the attention of a nation in the throes of an opioid crisis looking for ways to stem what experts have dubbed an epidemic. ...

Patients receive most opioids at the doctor's office, not the ER

January 16, 2018
Around the country, state legislatures and hospitals have tightened emergency room prescribing guidelines for opioids to curb the addiction epidemic, but a new USC study shows that approach diverts attention from the main ...

FDA bans use of opioid-containing cough meds by kids

January 12, 2018
(HealthDay)—Trying to put a dent in the ongoing opioid addiction crisis, the U.S. Food and Drug Administration on Thursday slapped strict new restrictions on the use of opioid-containing cold and cough products by kids.

Taking ibuprofen for long periods found to alter human testicular physiology

January 9, 2018
A team of researchers from Denmark and France has found that taking regular doses of the pain reliever ibuprofen over a long period of time can lead to a disorder in men called compensated hypogonadism. In their paper published ...

Nearly one-third of Canadians have used opioids: study

January 9, 2018
Nearly one in three Canadians (29 percent) have used "some form of opioids" in the past five years, according to data released Tuesday as widespread fentanyl overdoses continue to kill.

Growing opioid epidemic forcing more children into foster care

January 8, 2018
The opioid epidemic has become so severe it's considered a national public health emergency. Addiction to prescription painkillers, such as oxycodone and morphine, has contributed to a dramatic rise in overdose deaths and ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.